Quality and time-to-market are two key factors in the successful development of a new product. WACKER FINE CHEMICALS meets these challenges in the production of top-notch products that meet your exact specifications and are geared toward maximizing the benefit to you. Our research and development expertise, built up over many decades, has made WACKER a preferred partner for customers in the life sciences and consumer care industries – especially for highly challenging biotech custom-manufacturing projects. This is the result of our experienced, highly-qualified R&D teams, state-of-the-art research labs, flexible pilot plants, multifunctional production facilities, and established systems for implementing and monitoring both quality and sustainability.

With over 20 years’ experience working with microbial systems Wacker Biotech GmbH¹ is an attractive partner for contract-manufacturing of therapeutic proteins – regardless of whether the product is intended for clinical trials or market supply. Our focus is on development of stable, high-efficiency processes, and production in our GMP-compliant and auditedmulti-functional facilities. WACKER’s secretion system enables highly efficient extracellular production of proteins using an E. coli K12 based strain. The WACKER high cell-density fermentation system achieves extremely high space/time yields. You can implement these exceptional technologies in your project, or transfer your existing processes to our facilities. Our project managers work in close collaboration with you to ensure an ongoing flow of communication and precise adherence to schedules.

¹ Wacker Biotech GmbH is a wholly-owned WACKER subsidiary, operating since early 2005 as the direct successor of ProThera GmbH.